Form 4: Thermo Fisher Scientific Director Acquires Additional Phantom Stock Units Through Deferred Compensation Plan

Dion J. Weisler, a Director at Thermo Fisher Scientific Inc., acquired 91.85 phantom stock units as part of the company's Deferred Compensation Plan for Directors.

Summary

• Dion J. Weisler, a Director of Thermo Fisher Scientific Inc. (TMO), acquired 91.85 phantom stock units.
• The transaction occurred on June 28, 2025.
• These units were acquired at a price of $408.28 per unit.
• The acquisition was made pursuant to the Issuer's Deferred Compensation Plan for Directors.
• Following this transaction, Dion J. Weisler beneficially owns a total of 2,493.17 phantom stock units.
• Phantom stock units are convertible into Common Stock on a 1-for-1 basis.
• Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end.
• The shares are distributable as stock upon cessation of director service (for any reason) or a change of control.

Sentiment

Score: 7

Explanation: The filing indicates a routine, positive event of a director increasing their stake through a deferred compensation plan, which is generally viewed favorably as it aligns interests. No negative information is present.

Positives

• Director Dion J. Weisler increased his beneficial ownership in Thermo Fisher Scientific Inc. by acquiring 91.85 phantom stock units.
• The acquisition was part of a pre-existing Deferred Compensation Plan for Directors, indicating a structured approach to executive compensation and alignment of interests with shareholders.

Future Outlook

The phantom stock units are distributable as common stock upon cessation of director service or a change of control, aligning the director's long-term interests with the company's performance.

Management Comments

• Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end.

Industry Context

This transaction is a routine insider filing for deferred compensation, common across various industries for aligning director incentives with shareholder value. It does not indicate any specific industry trends beyond standard corporate governance practices.

Comparison to Industry Standards

• Deferred compensation plans for directors, where retainers are converted into equity units, are a common practice among publicly traded companies, including those in the life sciences and healthcare technology sectors like Thermo Fisher Scientific.
• This type of compensation structure is generally viewed as an industry standard for aligning the interests of board members with long-term shareholder value, similar to practices at peers such as Danaher Corporation or Agilent Technologies.

Corporate Governance

Related Party Transactions

• Acquisition of 91.85 phantom stock units by Director Dion J. Weisler through the Issuer's Deferred Compensation Plan for Directors, where directors' retainers are deferred quarterly as Common Stock units.

Stakeholder Impact

• Shareholders: The transaction aligns the director's financial interests with long-term shareholder value through equity-based compensation.
• Management: Reinforces the existing compensation structure for directors, promoting stability and long-term commitment.

Next Steps

• The phantom stock units will be converted into common stock and distributed upon cessation of director service or a change of control.

Key Dates

Keywords

Thermo Fisher Scientific, TMO, SEC Form 4, Insider Transaction, Phantom Stock Units, Deferred Compensation, Director Compensation, Stock Acquisition